News & Updates

Brolucizumab shows favourable benefit–risk profile in diabetic macular oedema

01 Feb 2022

At a dose of 6 mg, brolucizumab yields substantial visual gains and anatomical improvements in patients with diabetic macular oedema without increasing the risk of serious adverse ocular events when compared with aflibercept, according to data from two phase III trials.

Brolucizumab shows favourable benefit–risk profile in diabetic macular oedema

01 Feb 2022

Low-level light therapy may speed up repair of radiation therapy-induced skin damage

01 Feb 2022 by

Continuous exposure to radiation during cancer therapy promotes ulceration of tissues or radionecrosis, and a recent study revealed that the use of low-level light therapy may accelerate the resolution of skin damage by up to 50 percent.

Low-level light therapy may speed up repair of radiation therapy-induced skin damage

01 Feb 2022

High haemoglobin glycation index tied to telomere attrition

01 Feb 2022

A negative association exists between haemoglobin glycation index (HGI) and telomere attrition, independent of HbA1c, according to a study. Tumour necrosis factor (TNF) α mediates the association between HGI and telomere length.

High haemoglobin glycation index tied to telomere attrition

01 Feb 2022

Persistent dysglycaemia dims tuberculosis treatment outcomes

01 Feb 2022

Among patients with tuberculosis (TB) infection, treatment outcomes seem unfavourable in the presence of persistent dysglycaemia, as reported in a study.

Persistent dysglycaemia dims tuberculosis treatment outcomes

01 Feb 2022

KVD900 shows promise in early trial, gives hope to hereditary angioedema patients

01 Feb 2022

KVD900, and oral inhibitor of plasma kallikrein (PKa), safely and rapidly induces near-complete PKa inhibition, reports two phase I studies.

KVD900 shows promise in early trial, gives hope to hereditary angioedema patients

01 Feb 2022

Treatment adherence yields QoL gains in congenital adrenal hyperplasia patients

31 Jan 2022

Among teens and adults with congenital adrenal hyperplasia (CAH), adherence to treatment regimens, rather than type of glucocorticoid, is the factor that affects quality of life (QoL), according to a study.

Treatment adherence yields QoL gains in congenital adrenal hyperplasia patients

31 Jan 2022

Plecanatide may be safely administered with antacid

31 Jan 2022 by

Acid suppression therapy appears to exert no meaningful effect on the efficacy or safety of plecanatide when administered concomitantly, according to a study.

Plecanatide may be safely administered with antacid

31 Jan 2022

Postop adjuvant treatment yields survival benefit for stage IIB-III oesophageal SCC

31 Jan 2022 by

The addition of postoperative radiotherapy (PORT) or postoperative concurrent chemoradiotherapy (POCRT) to surgery led to significant improvements in disease-free survival (DFS) and overall survival (OS) in individuals with pathological stage IIB-III oesophageal squamous cell carcinoma (SCC) compared with surgery alone, a prospective phase III study from China suggests.

Postop adjuvant treatment yields survival benefit for stage IIB-III oesophageal SCC

31 Jan 2022

What predisposes schizophrenia patients to aggression?

31 Jan 2022 by

In schizophrenia patients with related psychoses, physical aggression seems to be higher among men, those with lower education, and those diagnosed at an older age, according to a recent Singapore study.

What predisposes schizophrenia patients to aggression?

31 Jan 2022

Secukinumab safe, effective in children with moderate to severe plaque psoriasis

31 Jan 2022

Treatment with either low- or high-dose secukinumab is effective and well tolerated in paediatric patients with moderate to severe plaque psoriasis, a study has shown.

Secukinumab safe, effective in children with moderate to severe plaque psoriasis

31 Jan 2022

News & Updates

Filter by Specialty:

Specialty:

Brolucizumab shows favourable benefit–risk profile in diabetic macular oedema

Brolucizumab shows favourable benefit–risk profile in diabetic macular oedema

Low-level light therapy may speed up repair of radiation therapy-induced skin damage

Low-level light therapy may speed up repair of radiation therapy-induced skin damage

High haemoglobin glycation index tied to telomere attrition

High haemoglobin glycation index tied to telomere attrition

Persistent dysglycaemia dims tuberculosis treatment outcomes

Persistent dysglycaemia dims tuberculosis treatment outcomes

KVD900 shows promise in early trial, gives hope to hereditary angioedema patients

KVD900 shows promise in early trial, gives hope to hereditary angioedema patients

Treatment adherence yields QoL gains in congenital adrenal hyperplasia patients

Treatment adherence yields QoL gains in congenital adrenal hyperplasia patients

Plecanatide may be safely administered with antacid

Plecanatide may be safely administered with antacid

Postop adjuvant treatment yields survival benefit for stage IIB-III oesophageal SCC

Postop adjuvant treatment yields survival benefit for stage IIB-III oesophageal SCC

What predisposes schizophrenia patients to aggression?

What predisposes schizophrenia patients to aggression?

Secukinumab safe, effective in children with moderate to severe plaque psoriasis

Secukinumab safe, effective in children with moderate to severe plaque psoriasis